nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.0158	0.0216	CcSEcCtD
Remifentanil—Ache—Lovastatin—atherosclerosis	0.0153	0.0208	CcSEcCtD
Remifentanil—Ache—Simvastatin—atherosclerosis	0.0143	0.0195	CcSEcCtD
Remifentanil—Creatine phosphokinase increased—Lovastatin—atherosclerosis	0.0134	0.0183	CcSEcCtD
Remifentanil—Creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.0132	0.0179	CcSEcCtD
Remifentanil—Ache—Pravastatin—atherosclerosis	0.0129	0.0176	CcSEcCtD
Remifentanil—Creatine phosphokinase increased—Simvastatin—atherosclerosis	0.0126	0.0171	CcSEcCtD
Remifentanil—Blood creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.0121	0.0165	CcSEcCtD
Remifentanil—Creatine phosphokinase increased—Pravastatin—atherosclerosis	0.0114	0.0155	CcSEcCtD
Remifentanil—Blood creatine phosphokinase increased—Lovastatin—atherosclerosis	0.0103	0.014	CcSEcCtD
Remifentanil—Blood creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.0101	0.0137	CcSEcCtD
Remifentanil—Blood creatine phosphokinase increased—Simvastatin—atherosclerosis	0.00959	0.0131	CcSEcCtD
Remifentanil—Heartburn—Niacin—atherosclerosis	0.00881	0.012	CcSEcCtD
Remifentanil—Heartburn—Pravastatin—atherosclerosis	0.00867	0.0118	CcSEcCtD
Remifentanil—Blood creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00867	0.0118	CcSEcCtD
Remifentanil—Haemoptysis—Niacin—atherosclerosis	0.00819	0.0112	CcSEcCtD
Remifentanil—Laryngospasm—Niacin—atherosclerosis	0.00812	0.0111	CcSEcCtD
Remifentanil—Nightmare—Rosuvastatin—atherosclerosis	0.00804	0.0109	CcSEcCtD
Remifentanil—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00766	0.0104	CcSEcCtD
Remifentanil—Sleep disorder—Rosuvastatin—atherosclerosis	0.00698	0.00951	CcSEcCtD
Remifentanil—Amnesia—Rosuvastatin—atherosclerosis	0.00643	0.00876	CcSEcCtD
Remifentanil—Nightmare—Simvastatin—atherosclerosis	0.00637	0.00868	CcSEcCtD
Remifentanil—Muscle twitching—Niacin—atherosclerosis	0.00617	0.0084	CcSEcCtD
Remifentanil—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00586	0.00798	CcSEcCtD
Remifentanil—Nightmare—Pravastatin—atherosclerosis	0.00576	0.00785	CcSEcCtD
Remifentanil—Sleep disorder—Simvastatin—atherosclerosis	0.00554	0.00754	CcSEcCtD
Remifentanil—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00548	0.00747	CcSEcCtD
Remifentanil—Amnesia—Lovastatin—atherosclerosis	0.00545	0.00742	CcSEcCtD
Remifentanil—Amnesia—Ezetimibe—atherosclerosis	0.00535	0.00728	CcSEcCtD
Remifentanil—Amnesia—Simvastatin—atherosclerosis	0.0051	0.00694	CcSEcCtD
Remifentanil—Atrial fibrillation—Simvastatin—atherosclerosis	0.00506	0.00689	CcSEcCtD
Remifentanil—Hepatic function abnormal—Niacin—atherosclerosis	0.00503	0.00686	CcSEcCtD
Remifentanil—Bronchitis—Rosuvastatin—atherosclerosis	0.00502	0.00684	CcSEcCtD
Remifentanil—Sleep disorder—Pravastatin—atherosclerosis	0.005	0.00681	CcSEcCtD
Remifentanil—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00496	0.00675	CcSEcCtD
Remifentanil—Atrial fibrillation—Niacin—atherosclerosis	0.00464	0.00632	CcSEcCtD
Remifentanil—Amnesia—Pravastatin—atherosclerosis	0.00461	0.00628	CcSEcCtD
Remifentanil—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00449	0.00612	CcSEcCtD
Remifentanil—Haematuria—Rosuvastatin—atherosclerosis	0.00444	0.00605	CcSEcCtD
Remifentanil—Abdominal discomfort—Lovastatin—atherosclerosis	0.00424	0.00578	CcSEcCtD
Remifentanil—Urinary retention—Niacin—atherosclerosis	0.00418	0.0057	CcSEcCtD
Remifentanil—Pharyngitis—Rosuvastatin—atherosclerosis	0.00415	0.00565	CcSEcCtD
Remifentanil—Bronchitis—Simvastatin—atherosclerosis	0.00398	0.00542	CcSEcCtD
Remifentanil—Abdominal discomfort—Simvastatin—atherosclerosis	0.00397	0.00541	CcSEcCtD
Remifentanil—Nasopharyngitis—Pravastatin—atherosclerosis	0.00387	0.00527	CcSEcCtD
Remifentanil—Dysphagia—Niacin—atherosclerosis	0.0038	0.00518	CcSEcCtD
Remifentanil—Arrhythmia—Rosuvastatin—atherosclerosis	0.00374	0.00509	CcSEcCtD
Remifentanil—Bronchitis—Niacin—atherosclerosis	0.00366	0.00498	CcSEcCtD
Remifentanil—Dysuria—Pravastatin—atherosclerosis	0.0035	0.00477	CcSEcCtD
Remifentanil—Pharyngitis—Ezetimibe—atherosclerosis	0.00345	0.0047	CcSEcCtD
Remifentanil—Flushing—Lovastatin—atherosclerosis	0.00329	0.00448	CcSEcCtD
Remifentanil—Sweating—Niacin—atherosclerosis	0.00325	0.00443	CcSEcCtD
Remifentanil—Flushing—Ezetimibe—atherosclerosis	0.00323	0.00439	CcSEcCtD
Remifentanil—Chills—Lovastatin—atherosclerosis	0.00318	0.00433	CcSEcCtD
Remifentanil—Cough—Rosuvastatin—atherosclerosis	0.00318	0.00433	CcSEcCtD
Remifentanil—Angiopathy—Ezetimibe—atherosclerosis	0.00315	0.00429	CcSEcCtD
Remifentanil—Immune system disorder—Ezetimibe—atherosclerosis	0.00314	0.00428	CcSEcCtD
Remifentanil—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00313	0.00427	CcSEcCtD
Remifentanil—Flushing—Simvastatin—atherosclerosis	0.00308	0.00419	CcSEcCtD
Remifentanil—Haemoglobin—Niacin—atherosclerosis	0.00306	0.00417	CcSEcCtD
Remifentanil—Haemorrhage—Niacin—atherosclerosis	0.00304	0.00414	CcSEcCtD
Remifentanil—Erythema—Ezetimibe—atherosclerosis	0.00303	0.00412	CcSEcCtD
Remifentanil—Confusional state—Rosuvastatin—atherosclerosis	0.003	0.00408	CcSEcCtD
Remifentanil—Pharyngitis—Pravastatin—atherosclerosis	0.00297	0.00405	CcSEcCtD
Remifentanil—Chills—Simvastatin—atherosclerosis	0.00297	0.00405	CcSEcCtD
Remifentanil—Visual impairment—Niacin—atherosclerosis	0.00293	0.00399	CcSEcCtD
Remifentanil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00291	0.00397	CcSEcCtD
Remifentanil—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00291	0.00396	CcSEcCtD
Remifentanil—Tremor—Lovastatin—atherosclerosis	0.00289	0.00394	CcSEcCtD
Remifentanil—Visual impairment—Pravastatin—atherosclerosis	0.00289	0.00393	CcSEcCtD
Remifentanil—Erythema—Simvastatin—atherosclerosis	0.00289	0.00393	CcSEcCtD
Remifentanil—Flushing—Niacin—atherosclerosis	0.00282	0.00385	CcSEcCtD
Remifentanil—Anaemia—Ezetimibe—atherosclerosis	0.0028	0.00381	CcSEcCtD
Remifentanil—Cardiac disorder—Pravastatin—atherosclerosis	0.00278	0.00379	CcSEcCtD
Remifentanil—Flushing—Pravastatin—atherosclerosis	0.00278	0.00379	CcSEcCtD
Remifentanil—Angiopathy—Niacin—atherosclerosis	0.00276	0.00376	CcSEcCtD
Remifentanil—Chills—Niacin—atherosclerosis	0.00273	0.00372	CcSEcCtD
Remifentanil—Arrhythmia—Niacin—atherosclerosis	0.00272	0.0037	CcSEcCtD
Remifentanil—Tremor—Simvastatin—atherosclerosis	0.0027	0.00368	CcSEcCtD
Remifentanil—Chills—Pravastatin—atherosclerosis	0.00269	0.00366	CcSEcCtD
Remifentanil—Arrhythmia—Pravastatin—atherosclerosis	0.00268	0.00365	CcSEcCtD
Remifentanil—Paraesthesia—Rosuvastatin—atherosclerosis	0.00267	0.00363	CcSEcCtD
Remifentanil—Anaemia—Simvastatin—atherosclerosis	0.00267	0.00363	CcSEcCtD
Remifentanil—Erythema—Niacin—atherosclerosis	0.00265	0.00361	CcSEcCtD
Remifentanil—Cough—Ezetimibe—atherosclerosis	0.00264	0.0036	CcSEcCtD
Remifentanil—Anxiety—Lovastatin—atherosclerosis	0.00262	0.00356	CcSEcCtD
Remifentanil—Dyspepsia—Rosuvastatin—atherosclerosis	0.00262	0.00356	CcSEcCtD
Remifentanil—Hypertension—Ezetimibe—atherosclerosis	0.00261	0.00356	CcSEcCtD
Remifentanil—Dry mouth—Lovastatin—atherosclerosis	0.00257	0.0035	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00256	0.00348	CcSEcCtD
Remifentanil—Pain—Rosuvastatin—atherosclerosis	0.00254	0.00346	CcSEcCtD
Remifentanil—Constipation—Rosuvastatin—atherosclerosis	0.00254	0.00346	CcSEcCtD
Remifentanil—Confusional state—Lovastatin—atherosclerosis	0.00254	0.00346	CcSEcCtD
Remifentanil—Dry mouth—Ezetimibe—atherosclerosis	0.00252	0.00343	CcSEcCtD
Remifentanil—Anaphylactic shock—Lovastatin—atherosclerosis	0.00252	0.00343	CcSEcCtD
Remifentanil—Confusional state—Ezetimibe—atherosclerosis	0.00249	0.00339	CcSEcCtD
Remifentanil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00247	0.00336	CcSEcCtD
Remifentanil—Thrombocytopenia—Lovastatin—atherosclerosis	0.00247	0.00336	CcSEcCtD
Remifentanil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00245	0.00333	CcSEcCtD
Remifentanil—Anxiety—Simvastatin—atherosclerosis	0.00245	0.00333	CcSEcCtD
Remifentanil—Tremor—Pravastatin—atherosclerosis	0.00244	0.00333	CcSEcCtD
Remifentanil—Nervous system disorder—Ezetimibe—atherosclerosis	0.00242	0.0033	CcSEcCtD
Remifentanil—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00242	0.00329	CcSEcCtD
Remifentanil—Anaemia—Pravastatin—atherosclerosis	0.00241	0.00328	CcSEcCtD
Remifentanil—Skin disorder—Ezetimibe—atherosclerosis	0.0024	0.00327	CcSEcCtD
Remifentanil—Syncope—Niacin—atherosclerosis	0.00238	0.00324	CcSEcCtD
Remifentanil—Confusional state—Simvastatin—atherosclerosis	0.00237	0.00323	CcSEcCtD
Remifentanil—Urticaria—Rosuvastatin—atherosclerosis	0.00236	0.00321	CcSEcCtD
Remifentanil—Oedema—Simvastatin—atherosclerosis	0.00236	0.00321	CcSEcCtD
Remifentanil—Anaphylactic shock—Simvastatin—atherosclerosis	0.00236	0.00321	CcSEcCtD
Remifentanil—Loss of consciousness—Niacin—atherosclerosis	0.00233	0.00317	CcSEcCtD
Remifentanil—Cough—Niacin—atherosclerosis	0.00231	0.00315	CcSEcCtD
Remifentanil—Thrombocytopenia—Simvastatin—atherosclerosis	0.00231	0.00314	CcSEcCtD
Remifentanil—Cough—Pravastatin—atherosclerosis	0.00228	0.0031	CcSEcCtD
Remifentanil—Paraesthesia—Lovastatin—atherosclerosis	0.00226	0.00308	CcSEcCtD
Remifentanil—Hypertension—Pravastatin—atherosclerosis	0.00225	0.00307	CcSEcCtD
Remifentanil—Dyspnoea—Lovastatin—atherosclerosis	0.00224	0.00306	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00224	0.00305	CcSEcCtD
Remifentanil—Paraesthesia—Ezetimibe—atherosclerosis	0.00222	0.00302	CcSEcCtD
Remifentanil—Dyspepsia—Lovastatin—atherosclerosis	0.00222	0.00302	CcSEcCtD
Remifentanil—Anxiety—Pravastatin—atherosclerosis	0.00221	0.00301	CcSEcCtD
Remifentanil—Dry mouth—Niacin—atherosclerosis	0.00221	0.003	CcSEcCtD
Remifentanil—Dyspnoea—Ezetimibe—atherosclerosis	0.0022	0.003	CcSEcCtD
Remifentanil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00219	0.00298	CcSEcCtD
Remifentanil—Dyspepsia—Ezetimibe—atherosclerosis	0.00217	0.00296	CcSEcCtD
Remifentanil—Oedema—Niacin—atherosclerosis	0.00216	0.00294	CcSEcCtD
Remifentanil—Anaphylactic shock—Niacin—atherosclerosis	0.00216	0.00294	CcSEcCtD
Remifentanil—Constipation—Lovastatin—atherosclerosis	0.00215	0.00293	CcSEcCtD
Remifentanil—Pain—Lovastatin—atherosclerosis	0.00215	0.00293	CcSEcCtD
Remifentanil—Confusional state—Pravastatin—atherosclerosis	0.00215	0.00292	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00213	0.0029	CcSEcCtD
Remifentanil—Anaphylactic shock—Pravastatin—atherosclerosis	0.00213	0.0029	CcSEcCtD
Remifentanil—Oedema—Pravastatin—atherosclerosis	0.00213	0.0029	CcSEcCtD
Remifentanil—Shock—Niacin—atherosclerosis	0.00213	0.0029	CcSEcCtD
Remifentanil—Paraesthesia—Simvastatin—atherosclerosis	0.00211	0.00288	CcSEcCtD
Remifentanil—Pain—Ezetimibe—atherosclerosis	0.00211	0.00288	CcSEcCtD
Remifentanil—Constipation—Ezetimibe—atherosclerosis	0.00211	0.00288	CcSEcCtD
Remifentanil—Tachycardia—Niacin—atherosclerosis	0.00211	0.00287	CcSEcCtD
Remifentanil—Pruritus—Rosuvastatin—atherosclerosis	0.0021	0.00286	CcSEcCtD
Remifentanil—Skin disorder—Niacin—atherosclerosis	0.0021	0.00286	CcSEcCtD
Remifentanil—Dyspnoea—Simvastatin—atherosclerosis	0.0021	0.00286	CcSEcCtD
Remifentanil—Hyperhidrosis—Niacin—atherosclerosis	0.00209	0.00285	CcSEcCtD
Remifentanil—Thrombocytopenia—Pravastatin—atherosclerosis	0.00208	0.00284	CcSEcCtD
Remifentanil—Feeling abnormal—Lovastatin—atherosclerosis	0.00207	0.00283	CcSEcCtD
Remifentanil—Dyspepsia—Simvastatin—atherosclerosis	0.00207	0.00282	CcSEcCtD
Remifentanil—Hyperhidrosis—Pravastatin—atherosclerosis	0.00206	0.0028	CcSEcCtD
Remifentanil—Feeling abnormal—Ezetimibe—atherosclerosis	0.00204	0.00277	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00203	0.00277	CcSEcCtD
Remifentanil—Diarrhoea—Rosuvastatin—atherosclerosis	0.00203	0.00277	CcSEcCtD
Remifentanil—Hypotension—Niacin—atherosclerosis	0.00202	0.00275	CcSEcCtD
Remifentanil—Pain—Simvastatin—atherosclerosis	0.00201	0.00274	CcSEcCtD
Remifentanil—Constipation—Simvastatin—atherosclerosis	0.00201	0.00274	CcSEcCtD
Remifentanil—Urticaria—Lovastatin—atherosclerosis	0.002	0.00272	CcSEcCtD
Remifentanil—Body temperature increased—Lovastatin—atherosclerosis	0.00199	0.00271	CcSEcCtD
Remifentanil—Dizziness—Rosuvastatin—atherosclerosis	0.00196	0.00268	CcSEcCtD
Remifentanil—Urticaria—Ezetimibe—atherosclerosis	0.00196	0.00267	CcSEcCtD
Remifentanil—Body temperature increased—Ezetimibe—atherosclerosis	0.00195	0.00266	CcSEcCtD
Remifentanil—Paraesthesia—Niacin—atherosclerosis	0.00194	0.00264	CcSEcCtD
Remifentanil—Feeling abnormal—Simvastatin—atherosclerosis	0.00194	0.00264	CcSEcCtD
Remifentanil—Dyspnoea—Niacin—atherosclerosis	0.00193	0.00263	CcSEcCtD
Remifentanil—Somnolence—Niacin—atherosclerosis	0.00192	0.00262	CcSEcCtD
Remifentanil—Paraesthesia—Pravastatin—atherosclerosis	0.00191	0.0026	CcSEcCtD
Remifentanil—Dyspepsia—Niacin—atherosclerosis	0.0019	0.00259	CcSEcCtD
Remifentanil—Dyspnoea—Pravastatin—atherosclerosis	0.0019	0.00258	CcSEcCtD
Remifentanil—Dyspepsia—Pravastatin—atherosclerosis	0.00187	0.00255	CcSEcCtD
Remifentanil—Rash—Rosuvastatin—atherosclerosis	0.00187	0.00255	CcSEcCtD
Remifentanil—Dermatitis—Rosuvastatin—atherosclerosis	0.00187	0.00255	CcSEcCtD
Remifentanil—Urticaria—Simvastatin—atherosclerosis	0.00187	0.00255	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Niacin—atherosclerosis	0.00187	0.00254	CcSEcCtD
Remifentanil—Body temperature increased—Simvastatin—atherosclerosis	0.00186	0.00254	CcSEcCtD
Remifentanil—Headache—Rosuvastatin—atherosclerosis	0.00186	0.00253	CcSEcCtD
Remifentanil—Hypersensitivity—Lovastatin—atherosclerosis	0.00186	0.00253	CcSEcCtD
Remifentanil—Pain—Niacin—atherosclerosis	0.00185	0.00252	CcSEcCtD
Remifentanil—Pain—Pravastatin—atherosclerosis	0.00182	0.00248	CcSEcCtD
Remifentanil—Constipation—Pravastatin—atherosclerosis	0.00182	0.00248	CcSEcCtD
Remifentanil—Hypersensitivity—Ezetimibe—atherosclerosis	0.00182	0.00248	CcSEcCtD
Remifentanil—Pruritus—Lovastatin—atherosclerosis	0.00178	0.00243	CcSEcCtD
Remifentanil—Nausea—Rosuvastatin—atherosclerosis	0.00176	0.0024	CcSEcCtD
Remifentanil—Feeling abnormal—Pravastatin—atherosclerosis	0.00175	0.00239	CcSEcCtD
Remifentanil—Pruritus—Ezetimibe—atherosclerosis	0.00175	0.00238	CcSEcCtD
Remifentanil—Hypersensitivity—Simvastatin—atherosclerosis	0.00174	0.00236	CcSEcCtD
Remifentanil—Diarrhoea—Lovastatin—atherosclerosis	0.00172	0.00235	CcSEcCtD
Remifentanil—Urticaria—Niacin—atherosclerosis	0.00172	0.00234	CcSEcCtD
Remifentanil—Body temperature increased—Niacin—atherosclerosis	0.00171	0.00233	CcSEcCtD
Remifentanil—Urticaria—Pravastatin—atherosclerosis	0.00169	0.0023	CcSEcCtD
Remifentanil—Diarrhoea—Ezetimibe—atherosclerosis	0.00169	0.0023	CcSEcCtD
Remifentanil—Body temperature increased—Pravastatin—atherosclerosis	0.00168	0.00229	CcSEcCtD
Remifentanil—Pruritus—Simvastatin—atherosclerosis	0.00167	0.00227	CcSEcCtD
Remifentanil—Dizziness—Lovastatin—atherosclerosis	0.00167	0.00227	CcSEcCtD
Remifentanil—Dizziness—Ezetimibe—atherosclerosis	0.00163	0.00222	CcSEcCtD
Remifentanil—Diarrhoea—Simvastatin—atherosclerosis	0.00161	0.00219	CcSEcCtD
Remifentanil—Vomiting—Lovastatin—atherosclerosis	0.0016	0.00218	CcSEcCtD
Remifentanil—Hypersensitivity—Niacin—atherosclerosis	0.00159	0.00217	CcSEcCtD
Remifentanil—Rash—Lovastatin—atherosclerosis	0.00159	0.00216	CcSEcCtD
Remifentanil—Dermatitis—Lovastatin—atherosclerosis	0.00159	0.00216	CcSEcCtD
Remifentanil—Headache—Lovastatin—atherosclerosis	0.00158	0.00215	CcSEcCtD
Remifentanil—Vomiting—Ezetimibe—atherosclerosis	0.00157	0.00214	CcSEcCtD
Remifentanil—Hypersensitivity—Pravastatin—atherosclerosis	0.00157	0.00214	CcSEcCtD
Remifentanil—Dizziness—Simvastatin—atherosclerosis	0.00156	0.00212	CcSEcCtD
Remifentanil—Rash—Ezetimibe—atherosclerosis	0.00156	0.00212	CcSEcCtD
Remifentanil—Dermatitis—Ezetimibe—atherosclerosis	0.00156	0.00212	CcSEcCtD
Remifentanil—Headache—Ezetimibe—atherosclerosis	0.00155	0.00211	CcSEcCtD
Remifentanil—Pruritus—Niacin—atherosclerosis	0.00153	0.00208	CcSEcCtD
Remifentanil—Pruritus—Pravastatin—atherosclerosis	0.00151	0.00205	CcSEcCtD
Remifentanil—Vomiting—Simvastatin—atherosclerosis	0.0015	0.00204	CcSEcCtD
Remifentanil—Alfentanil—ALB—atherosclerosis	0.0015	0.689	CrCbGaD
Remifentanil—Nausea—Lovastatin—atherosclerosis	0.0015	0.00204	CcSEcCtD
Remifentanil—Rash—Simvastatin—atherosclerosis	0.00148	0.00202	CcSEcCtD
Remifentanil—Dermatitis—Simvastatin—atherosclerosis	0.00148	0.00202	CcSEcCtD
Remifentanil—Diarrhoea—Niacin—atherosclerosis	0.00148	0.00201	CcSEcCtD
Remifentanil—Headache—Simvastatin—atherosclerosis	0.00148	0.00201	CcSEcCtD
Remifentanil—Nausea—Ezetimibe—atherosclerosis	0.00147	0.002	CcSEcCtD
Remifentanil—Diarrhoea—Pravastatin—atherosclerosis	0.00146	0.00198	CcSEcCtD
Remifentanil—Dizziness—Niacin—atherosclerosis	0.00143	0.00195	CcSEcCtD
Remifentanil—Dizziness—Pravastatin—atherosclerosis	0.00141	0.00192	CcSEcCtD
Remifentanil—Nausea—Simvastatin—atherosclerosis	0.0014	0.0019	CcSEcCtD
Remifentanil—Vomiting—Niacin—atherosclerosis	0.00137	0.00187	CcSEcCtD
Remifentanil—Rash—Niacin—atherosclerosis	0.00136	0.00186	CcSEcCtD
Remifentanil—Dermatitis—Niacin—atherosclerosis	0.00136	0.00185	CcSEcCtD
Remifentanil—Headache—Niacin—atherosclerosis	0.00135	0.00184	CcSEcCtD
Remifentanil—Vomiting—Pravastatin—atherosclerosis	0.00135	0.00184	CcSEcCtD
Remifentanil—Rash—Pravastatin—atherosclerosis	0.00134	0.00183	CcSEcCtD
Remifentanil—Dermatitis—Pravastatin—atherosclerosis	0.00134	0.00183	CcSEcCtD
Remifentanil—Headache—Pravastatin—atherosclerosis	0.00133	0.00182	CcSEcCtD
Remifentanil—Nausea—Niacin—atherosclerosis	0.00128	0.00175	CcSEcCtD
Remifentanil—Nausea—Pravastatin—atherosclerosis	0.00126	0.00172	CcSEcCtD
Remifentanil—Pethidine—ALB—atherosclerosis	0.000675	0.311	CrCbGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR2—atherosclerosis	0.000285	0.00108	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EDNRA—atherosclerosis	0.000285	0.00108	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000284	0.00108	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—AGT—atherosclerosis	0.000281	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KNG1—atherosclerosis	0.000278	0.00106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GHRL—atherosclerosis	0.000278	0.00105	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—UTS2—atherosclerosis	0.000277	0.00105	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGTR1—atherosclerosis	0.000276	0.00105	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL2—atherosclerosis	0.000274	0.00104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL4—atherosclerosis	0.000272	0.00103	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—KNG1—atherosclerosis	0.000268	0.00102	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000267	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL3—atherosclerosis	0.000266	0.00101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CX3CR1—atherosclerosis	0.000265	0.00101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASR—atherosclerosis	0.000265	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR2—atherosclerosis	0.000265	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000265	0.00101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CX3CL1—atherosclerosis	0.00026	0.000988	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—F2—atherosclerosis	0.000259	0.000985	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GHRL—atherosclerosis	0.000258	0.000981	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—EDN1—atherosclerosis	0.000258	0.000979	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCL5—atherosclerosis	0.000256	0.000972	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOA2—atherosclerosis	0.000255	0.000966	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA4—atherosclerosis	0.00025	0.000949	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CNR2—atherosclerosis	0.000247	0.000937	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL8—atherosclerosis	0.000247	0.000936	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MMP3—atherosclerosis	0.000246	0.000935	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KNG1—atherosclerosis	0.000244	0.000925	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000243	0.000924	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—UTS2—atherosclerosis	0.000243	0.000922	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGTR1—atherosclerosis	0.000242	0.00092	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EDNRA—atherosclerosis	0.000241	0.000914	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR2—atherosclerosis	0.000241	0.000914	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00024	0.000911	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GHRL—atherosclerosis	0.000235	0.000891	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EDN1—atherosclerosis	0.000234	0.000889	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CX3CR1—atherosclerosis	0.000233	0.000884	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASR—atherosclerosis	0.000233	0.000884	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL5—atherosclerosis	0.000232	0.000882	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL2—atherosclerosis	0.000231	0.000878	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL4—atherosclerosis	0.00023	0.000874	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CX3CL1—atherosclerosis	0.000228	0.000867	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—KNG1—atherosclerosis	0.000227	0.000861	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—EDN1—atherosclerosis	0.000226	0.000859	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000225	0.000856	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCL5—atherosclerosis	0.000224	0.000852	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PRKCG—atherosclerosis	0.000221	0.000839	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VWF—atherosclerosis	0.00022	0.000835	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOC3—atherosclerosis	0.000219	0.00083	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LDLR—atherosclerosis	0.000217	0.000825	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CNR2—atherosclerosis	0.000216	0.000822	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL8—atherosclerosis	0.000216	0.000821	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MMP3—atherosclerosis	0.000216	0.00082	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA2—atherosclerosis	0.000215	0.000817	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AGT—atherosclerosis	0.000214	0.000813	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000213	0.00081	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL3—atherosclerosis	0.000212	0.000806	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KNG1—atherosclerosis	0.000206	0.000782	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EDN1—atherosclerosis	0.000205	0.00078	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—UTS2—atherosclerosis	0.000205	0.000779	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.000205	0.000777	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL5—atherosclerosis	0.000204	0.000774	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NCF1—atherosclerosis	0.000203	0.000772	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—F2—atherosclerosis	0.000198	0.000751	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000197	0.000747	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASR—atherosclerosis	0.000197	0.000747	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGT—atherosclerosis	0.000194	0.000738	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PRKCG—atherosclerosis	0.000194	0.000735	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000193	0.000732	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VWF—atherosclerosis	0.000193	0.000732	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDNRA—atherosclerosis	0.000192	0.000729	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR2—atherosclerosis	0.000192	0.000729	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOC3—atherosclerosis	0.000192	0.000728	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000191	0.000726	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CYBA—atherosclerosis	0.000191	0.000725	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LDLR—atherosclerosis	0.000191	0.000723	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.00019	0.00072	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000189	0.000719	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGT—atherosclerosis	0.000188	0.000713	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GHRL—atherosclerosis	0.000187	0.00071	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLAT—atherosclerosis	0.000187	0.00071	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PARP1—atherosclerosis	0.000187	0.00071	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL3—atherosclerosis	0.000186	0.000706	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CNR2—atherosclerosis	0.000183	0.000694	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000183	0.000694	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000182	0.000693	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00018	0.000685	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—F2—atherosclerosis	0.00018	0.000682	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NCF1—atherosclerosis	0.000178	0.000677	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000174	0.000659	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—F2—atherosclerosis	0.000173	0.000658	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000172	0.000654	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000172	0.000653	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGT—atherosclerosis	0.00017	0.000647	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR2—atherosclerosis	0.000168	0.000639	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDNRA—atherosclerosis	0.000168	0.000639	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CYBA—atherosclerosis	0.000168	0.000636	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000166	0.00063	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KNG1—atherosclerosis	0.000164	0.000623	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PARP1—atherosclerosis	0.000164	0.000623	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLAT—atherosclerosis	0.000164	0.000623	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GHRL—atherosclerosis	0.000164	0.000623	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000164	0.000622	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGTR1—atherosclerosis	0.000163	0.00062	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VWF—atherosclerosis	0.000163	0.000619	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOC3—atherosclerosis	0.000162	0.000615	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LDLR—atherosclerosis	0.000161	0.000611	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL2—atherosclerosis	0.00016	0.000608	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLG—atherosclerosis	0.000159	0.000604	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000159	0.000602	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—F2—atherosclerosis	0.000158	0.000598	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL3—atherosclerosis	0.000157	0.000597	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000151	0.000572	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NCF1—atherosclerosis	0.000151	0.000572	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS3—atherosclerosis	0.000151	0.000572	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—F2—atherosclerosis	0.000147	0.000556	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP3—atherosclerosis	0.000145	0.000552	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF2—atherosclerosis	0.000145	0.00055	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGT—atherosclerosis	0.000144	0.000547	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KNG1—atherosclerosis	0.000144	0.000546	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGTR1—atherosclerosis	0.000143	0.000543	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000142	0.00054	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR2—atherosclerosis	0.000142	0.00054	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CYBA—atherosclerosis	0.000142	0.000538	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOB—atherosclerosis	0.000141	0.000534	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL2—atherosclerosis	0.00014	0.000533	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00014	0.000533	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLG—atherosclerosis	0.000139	0.000529	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000139	0.000529	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GHRL—atherosclerosis	0.000139	0.000526	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLAT—atherosclerosis	0.000139	0.000526	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PARP1—atherosclerosis	0.000139	0.000526	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDN1—atherosclerosis	0.000138	0.000525	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL5—atherosclerosis	0.000137	0.000521	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LPL—atherosclerosis	0.000134	0.00051	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—F2—atherosclerosis	0.000133	0.000505	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	0.000132	0.000501	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	0.000131	0.000495	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP3—atherosclerosis	0.000128	0.000484	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000127	0.000484	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SPP1—atherosclerosis	0.000127	0.000483	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF2—atherosclerosis	0.000127	0.000482	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	0.000127	0.000481	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOB—atherosclerosis	0.000123	0.000468	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000122	0.000464	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KNG1—atherosclerosis	0.000122	0.000462	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDN1—atherosclerosis	0.000121	0.000461	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000121	0.000459	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL5—atherosclerosis	0.00012	0.000457	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000119	0.00045	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLG—atherosclerosis	0.000118	0.000447	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LPL—atherosclerosis	0.000118	0.000447	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	0.000118	0.000447	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGT—atherosclerosis	0.000115	0.000436	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	0.000114	0.000434	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—atherosclerosis	0.000113	0.000427	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LEP—atherosclerosis	0.000113	0.000427	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000112	0.000424	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CAV1—atherosclerosis	0.000111	0.000423	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SPP1—atherosclerosis	0.000111	0.000423	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOA1—atherosclerosis	0.000111	0.000422	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	0.000111	0.000421	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP3—atherosclerosis	0.000108	0.000409	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ESR1—atherosclerosis	0.000107	0.000408	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF2—atherosclerosis	0.000107	0.000407	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—F2—atherosclerosis	0.000106	0.000403	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOB—atherosclerosis	0.000104	0.000396	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000103	0.000392	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	0.000103	0.000392	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDN1—atherosclerosis	0.000103	0.000389	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL5—atherosclerosis	0.000102	0.000386	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	0.000102	0.000386	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGT—atherosclerosis	0.000101	0.000382	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LPL—atherosclerosis	9.95e-05	0.000378	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LEP—atherosclerosis	9.87e-05	0.000375	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—atherosclerosis	9.87e-05	0.000375	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CAV1—atherosclerosis	9.78e-05	0.000371	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOA1—atherosclerosis	9.75e-05	0.00037	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	9.73e-05	0.000369	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	9.67e-05	0.000367	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INS—atherosclerosis	9.61e-05	0.000365	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—atherosclerosis	9.46e-05	0.000359	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SPP1—atherosclerosis	9.42e-05	0.000358	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ESR1—atherosclerosis	9.42e-05	0.000358	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	9.38e-05	0.000356	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—F2—atherosclerosis	9.3e-05	0.000353	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—atherosclerosis	9.3e-05	0.000353	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	8.9e-05	0.000338	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	8.83e-05	0.000335	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	8.72e-05	0.000331	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	8.53e-05	0.000324	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGT—atherosclerosis	8.51e-05	0.000323	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—atherosclerosis	8.43e-05	0.00032	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INS—atherosclerosis	8.43e-05	0.00032	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—atherosclerosis	8.34e-05	0.000317	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LEP—atherosclerosis	8.34e-05	0.000317	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—atherosclerosis	8.29e-05	0.000315	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CAV1—atherosclerosis	8.26e-05	0.000314	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA1—atherosclerosis	8.24e-05	0.000313	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—atherosclerosis	8.15e-05	0.00031	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ESR1—atherosclerosis	7.96e-05	0.000302	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2—atherosclerosis	7.86e-05	0.000299	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	7.74e-05	0.000294	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	7.53e-05	0.000286	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	7.48e-05	0.000284	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—atherosclerosis	7.39e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	7.22e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	7.21e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INS—atherosclerosis	7.12e-05	0.00027	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—atherosclerosis	7.11e-05	0.00027	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—atherosclerosis	7.01e-05	0.000266	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—atherosclerosis	6.89e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—atherosclerosis	6.76e-05	0.000257	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	6.69e-05	0.000254	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	6.58e-05	0.00025	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	6.56e-05	0.000249	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	6.56e-05	0.000249	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	6.54e-05	0.000248	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	6.33e-05	0.00024	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—atherosclerosis	6.25e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—atherosclerosis	6.23e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	6.07e-05	0.000231	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—atherosclerosis	6.01e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—atherosclerosis	5.93e-05	0.000225	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	5.87e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	5.77e-05	0.000219	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	5.75e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	5.75e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	5.57e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	5.54e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	5.35e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	5.33e-05	0.000202	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—atherosclerosis	5.27e-05	0.0002	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—atherosclerosis	5.27e-05	0.0002	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	5.04e-05	0.000191	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—atherosclerosis	5.01e-05	0.00019	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	4.96e-05	0.000188	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	4.89e-05	0.000186	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	4.87e-05	0.000185	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	4.86e-05	0.000185	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	4.5e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—atherosclerosis	4.46e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	4.26e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—atherosclerosis	4.2e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	4.13e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—atherosclerosis	3.87e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—atherosclerosis	3.68e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—atherosclerosis	3.4e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—atherosclerosis	3.11e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—atherosclerosis	2.87e-05	0.000109	CbGpPWpGaD
